comprehensive -WSS

comprehensive

author：entertainment 2025-10-02 23:45:18 - browse：2219

Vials and packaging for Leqembi, a new Alzheimer's medication approved in the U.S., but not yet in Europe. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

LONDON — Starting Sunday, Alzheimer’s specialists will gather for a major conference in Amsterdam, convening at a time when the field, depending on which expert you ask, has some rare momentum behind it, with new therapies starting to show benefits for patients.

But despite the hard-won victories, the arrival of the new therapies presents a new set of challenges in Europe as countries plan for their possible rollouts, scientists and doctors told STAT.

Health systems will have to adapt to diagnose people earlier and monitor them for side effects associated with the treatments. If their medicines win European approval, companies will have to strike reimbursement deals in all member states, a process that often leaves some countries waiting years for new drugs to become available. The hurdles mean the therapies will likely be offered only at certain centers initially, constraining how many patients have access to them, doctors from across Europe said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： HIPAA doesn't protect reproductive records from prosecutors

leisure time

WSS

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Pentagon will tighten controls on classified information after Discord leak

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

HIPAA doesn't protect reproductive records from prosecutors

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

What to know about Saharan dust affecting the US and how it can affect health

hotspot

comprehensive

leisure time

Virginia high school admissions case could be legal follow

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

What does generative AI mean for health care? We asked experts

Following judge's order, DOJ releases slightly less

DIEP, the 'gold standard' of breast reconstruction, is under threat

5 shark bites reported on Long Island as officials deploy surveillance drones

Cancer drug shortages should be causing more outrage

Condition critical? Britain's beloved but battered National Health Service turns 75

Medical records are filled with copy

FDA official pushes for dedicated emerging pathogens team

explore

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

How artificial intelligence is being used to detect, treat cancer

7 of the most gruesome medical devices in history

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

As Taiwan prepares for anti

focus

leisure time

hotspot

knowledge